You are here: Industry Insights > Market News > Pharmaceutical Manufacturing And Packaging Congress 2022 to be held in June

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

Hot Products

Propantheline Bromide

carbomer 974P

Coenzyme Q10

Refined Fish Oil

Black Currant Extract

Hydrocortisone

Pharmaceutical Manufacturing And Packaging Congress 2022 to be held in June

expresspharmaDecember 16, 2021

Tag: Packaging , pharmaceutical manufacturing , PHARMAP

Favorites

The Pharmaceutical Manufacturing and Packaging Congress (PHARMAP 2022) will take place on 20th and 21st June in Berlin, Germany.

The experts at the summit will deliberate upon the topics like challenges and strategies for pharmaceutical business transformation, integrated packaging design for a more sustainable pharma future, new innovations in pharmaceutical packaging and brand protection, transforming pharmaceuticals with robotic solutions and AI, and how to increase the flexibility and reliability of the supply chain in new realities.

The congress is the networking platform for more than 250 seasoned pharmaceutical professionals. Among participants, there are representatives like Bayer, Sandoz, Merck, Novartis, Roche, Genveon, Samsung Biologics, Pfizer and others.

Previous:CDC Warns of Coming Omicron Wave

Next:Antibody Response to SARS-CoV-2 Wanes Among Dialysis Patients

New CRO Focused on Cannabis-based Drug Trials Launched

Biotech NewswireMay 23, 2024

Cannovation Clinical Research Partners takes a holistic approach to assist businesses throughout the entire product lifecycle, encompassing product development, commercialization, and launch phases.

InnoCare Announces First Patient Dosed in Clinical Trial of BCL2 Inhibitor ICP-248 in Combination with Orelabrutinib as First-Line Therapy for Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma

PharmaSourcesMay 21, 2024

Sartorius to Advance Drug Discovery and Manufacturing with AI in Collaboration with NVIDIA

Biotech NewswireMay 17, 2024

Pharmaceutical Manufacturing And Packaging Congress 2022 to be held in June | Pharmasources.com

InnoCare Announces the Completion of Patient Enrollment in the Phase II Clinical Trial of ICP-488 for the Treatment of Psoriasis

PharmaSourcesMay 16, 2024

InnoCare announced the completion of patient enrollment for the phase II clinical trial of ICP-488, a TYK2 (tyrosine kinase 2) JH2 allosteric inhibitor, for the treatment of psoriasis.

Pharmaceutical Manufacturing And Packaging Congress 2022 to be held in June

Related News

New CRO Focused on Cannabis-based Drug Trials Launched

InnoCare Announces First Patient Dosed in Clinical Trial of BCL2 Inhibitor ICP-248 in Combination with Orelabrutinib as First-Line Therapy for Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma

Sartorius to Advance Drug Discovery and Manufacturing with AI in Collaboration with NVIDIA

InnoCare Announces the Completion of Patient Enrollment in the Phase II Clinical Trial of ICP-488 for the Treatment of Psoriasis

You may like